Zoetis | ZTS - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 58.94B 4.03B 2025-12
Align Technology USD 0 0 2024-12
Bayer EUR 30.68B 1.15B 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Coherus Biosciences USD 51.08M 496K 2025-12
Dentsply International USD 2.01B 9M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Henry Schein USD 2.33B 17M 2026-03
Idexx Laboratories USD 299.85M 74.99M 2026-03
Illumina USD 1.49B 0 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
J&J USD 37.53B 1.91B 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Merck USD 46.67B 77M 2026-03
Neogen USD 793.3M 374K 2025-12
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.62B 17.5M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Phibro Animal Health USD 597.68M 5.92M 2026-03
Quest Diagnostics USD 5.16B 12M 2026-03
Sanofi EUR 13.84B 1.88B 2026-03
Sanofi EUR 15.72B 150.06M 2025-12
Zoetis USD 9.04B 3M 2026-03